Advanced Proteome Therapeutics Corporation
APCH.V
TSX
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -306.95% | -376.98% | 84.58% | 141.40% | 145.16% |
| Total Depreciation and Amortization | -22.92% | 14.29% | 33.33% | 60.00% | 84.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 155.29% | 86.08% | -633.84% | -238.08% | -215.05% |
| Change in Net Operating Assets | -77.38% | 57.54% | 402.86% | 2,290.48% | 380.56% |
| Cash from Operations | -52.21% | -42.46% | -37.70% | -27.22% | -25.78% |
| Capital Expenditure | 95.48% | 95.48% | 100.00% | -711.76% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 546.57% | 27.03% | -- | -- | -- |
| Cash from Investing | 256.51% | 43.80% | 100.00% | 72.34% | -- |
| Total Debt Issued | -162.34% | -140.99% | -100.00% | -100.00% | 895.91% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 82.95% | -74.89% | -67.07% | -68.59% | -87.14% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -76.36% | -77.68% | -67.39% | -69.65% | -65.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -256.64% | -170.65% | -154.28% | -133.89% | -122.56% |